<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30200262</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1420-3049</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>23</Volume>                    <Issue>9</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Molecules (Basel, Switzerland)</Title>                <ISOAbbreviation>Molecules</ISOAbbreviation>            </Journal>            <ArticleTitle>Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">E2193</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules23092193</ELocationID>            <Abstract>                <AbstractText>Despite advances in breast cancer diagnosis and treatment, many patients still fail therapy, resulting in disease progression, recurrence, and reduced overall survival. Historically, much focus has been put on the intrinsic subtyping based in the presence (or absence) of classical immunohistochemistry (IHC) markers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-related protein (HER2). However, it is widely understood that tumors are composed of heterogeneous populations of cells with a hierarchical organization driven by cancer stem cells (CSCs). In breast tumors, this small population of cells displaying stem cell properties is known as breast CSCs (BCSCs). This rare population exhibit a CD44⁺/CD24<sup>-/low</sup> phenotype with high ALDH activity (ALDH⁺), and possesses higher tolerability to chemotherapy, hormone therapy, and radiotherapy and is able to reproduce the bulk of the tumor after reduction of cell populations sensitive to first-line therapy leading to disease relapse. In this review, we present special attention to BCSCs with future directions in the establishment of a therapy targeting this population. Drugs targeting the main BCSCs signaling pathways undergoing clinical trials are also summarized.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Palomeras</LastName>                    <ForeName>Sònia</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>New Therapeutic Targets Laboratory (TargetsLab) Oncology Unit, Department of Medical Sciences, University of Girona, Girona Institute for Biomedical Research, Emili Grahit 77, Girona 17003, Spain. sonia.palomeras@udg.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ruiz-Martínez</LastName>                    <ForeName>Santiago</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>New Therapeutic Targets Laboratory (TargetsLab) Oncology Unit, Department of Medical Sciences, University of Girona, Girona Institute for Biomedical Research, Emili Grahit 77, Girona 17003, Spain. santiago.ruiz@udg.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Puig</LastName>                    <ForeName>Teresa</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>New Therapeutic Targets Laboratory (TargetsLab) Oncology Unit, Department of Medical Sciences, University of Girona, Girona Institute for Biomedical Research, Emili Grahit 77, Girona 17003, Spain. teresa.puig@udg.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Molecules</MedlineTA>            <NlmUniqueID>100964009</NlmUniqueID>            <ISSNLinking>1420-3049</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Dis. 2014 Jun 12;5:e1287</RefSource>                <PMID Version="1">24922071</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2016 Nov;36(11):5681-5691</RefSource>                <PMID Version="1">27793889</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Aug 9;7(32):51408-51422</RefSource>                <PMID Version="1">27285982</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2002 Oct 11;277(41):38013-20</RefSource>                <PMID Version="1">12145277</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stem Cell Investig. 2017 Nov 07;4:87</RefSource>                <PMID Version="1">29270413</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stem Cells. 2013 Dec;31(12):2827-32</RefSource>                <PMID Version="1">24022994</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2004;6(6):R605-15</RefSource>                <PMID Version="1">15535842</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2013 Mar 1;73(5):1635-46</RefSource>                <PMID Version="1">23442322</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Cell Res. 2013 Oct 15;319(17):2739-46</RefSource>                <PMID Version="1">23850973</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2005 Jul 1;65(13):5506-11</RefSource>                <PMID Version="1">15994920</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Nanomedicine. 2016 Apr 05;11:1413-25</RefSource>                <PMID Version="1">27103799</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Med Chem. 2013;20(27):3358-69</RefSource>                <PMID Version="1">23651304</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Trends Mol Med. 2008 Oct;14(10):450-60</RefSource>                <PMID Version="1">18775674</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2009 Jul 1;15(13):4299-311</RefSource>                <PMID Version="1">19509143</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2009;11(1):R7</RefSource>                <PMID Version="1">19187537</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Mol Med. 2017 Sep;40(3):587-606</RefSource>                <PMID Version="1">28731148</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2012 Mar 20;12:96</RefSource>                <PMID Version="1">22433494</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stem Cell Investig. 2017 Nov 29;4:96</RefSource>                <PMID Version="1">29270422</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Stem Cell Res Ther. 2014 Mar;9(2):102-11</RefSource>                <PMID Version="1">24359139</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2011 Feb;8(2):97-106</RefSource>                <PMID Version="1">21151206</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 Nov;118(2):241-54</RefSource>                <PMID Version="1">19731012</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2011 Nov;130(2):387-98</RefSource>                <PMID Version="1">21188630</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Biophys Res Commun. 2014 Oct 10;453(1):112-6</RefSource>                <PMID Version="1">25261721</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1989 May 12;244(4905):707-12</RefSource>                <PMID Version="1">2470152</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2010 May 1;16(9):2580-90</RefSource>                <PMID Version="1">20388854</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Colloids Surf B Biointerfaces. 2016 Jul 1;143:532-546</RefSource>                <PMID Version="1">27045981</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 Jun;115(3):453-95</RefSource>                <PMID Version="1">18841463</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2008 Jun 1;68(11):4311-20</RefSource>                <PMID Version="1">18519691</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2000 Aug 17;406(6797):747-52</RefSource>                <PMID Version="1">10963602</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2011 Oct;121(10):3804-9</RefSource>                <PMID Version="1">21965337</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1987 Jan 9;235(4785):177-82</RefSource>                <PMID Version="1">3798106</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 1994 Feb 17;367(6464):645-8</RefSource>                <PMID Version="1">7509044</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2784-9</RefSource>                <PMID Version="1">22308314</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FEBS J. 2011 May;278(9):1429-43</RefSource>                <PMID Version="1">21362138</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2014 Feb;44(2):403-11</RefSource>                <PMID Version="1">24297508</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Onco Targets Ther. 2018 Jul 24;11:4263-4270</RefSource>                <PMID Version="1">30100733</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Springerplus. 2013 Jul 04;2(1):301</RefSource>                <PMID Version="1">23888272</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Differ. 2008 Mar;15(3):504-14</RefSource>                <PMID Version="1">18049477</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2003 May 15;17(10):1253-70</RefSource>                <PMID Version="1">12756227</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2006 Apr 21;281(16):10865-75</RefSource>                <PMID Version="1">16495219</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Stem Cell. 2007 Sep 13;1(3):313-23</RefSource>                <PMID Version="1">18371365</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Stem Cell. 2011 Sep 2;9(3):247-61</RefSource>                <PMID Version="1">21885020</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Cell Res. 2013 Jan 15;319(2):126-32</RefSource>                <PMID Version="1">22999864</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2006;8(5):R59</RefSource>                <PMID Version="1">17062128</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Oncol. 1998 Apr;15(1):20-6</RefSource>                <PMID Version="1">9643526</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Stem Cell. 2007 Nov;1(5):555-67</RefSource>                <PMID Version="1">18371393</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2008 Oct 16;27(47):6120-30</RefSource>                <PMID Version="1">18591932</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23</RefSource>                <PMID Version="1">12829800</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2010 Dec 20;5(12):e15630</RefSource>                <PMID Version="1">21187973</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2009 Aug 21;138(4):645-659</RefSource>                <PMID Version="1">19682730</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Jul 28;9(7):e102535</RefSource>                <PMID Version="1">25068516</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stem Cell Reports. 2015 Sep 8;5(3):378-91</RefSource>                <PMID Version="1">26300228</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2011;6(9):e24080</RefSource>                <PMID Version="1">21935375</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancers (Basel). 2015 Aug 11;7(3):1554-85</RefSource>                <PMID Version="1">26270676</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2018 Jan 16;8(1):829</RefSource>                <PMID Version="1">29339789</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1995 Feb 15;55(4):901-6</RefSource>                <PMID Version="1">7850807</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2008 May 16;133(4):704-15</RefSource>                <PMID Version="1">18485877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Exp Med Biol. 1991;284:85-95</RefSource>                <PMID Version="1">2053494</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2047-56</RefSource>                <PMID Version="1">27001847</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85</RefSource>                <PMID Version="1">17179479</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods Mol Biol. 2009;590:363-75</RefSource>                <PMID Version="1">19763516</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2012 Dec 15;131(12):2808-19</RefSource>                <PMID Version="1">22511343</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2008 May 7;100(9):672-9</RefSource>                <PMID Version="1">18445819</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Med (Berl). 2014 Feb;92(2):151-64</RefSource>                <PMID Version="1">24248265</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gastric Cancer. 2017 Mar;20(2):341-349</RefSource>                <PMID Version="1">27055559</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2008 Feb 15;22(4):436-48</RefSource>                <PMID Version="1">18281460</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Aug 16;7(33):52751-52765</RefSource>                <PMID Version="1">27409838</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2003 Sep 15;63(18):5821-8</RefSource>                <PMID Version="1">14522905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Gastroenterol. 2011 Feb 21;17(7):932-7</RefSource>                <PMID Version="1">21412503</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Cycle. 2011 May 1;10(9):1378-84</RefSource>                <PMID Version="1">21552008</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Lett. 2001 Nov 8;173(1):1-7</RefSource>                <PMID Version="1">11578802</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Carcinog. 2017 Jan;56(1):3-17</RefSource>                <PMID Version="1">26207516</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Biochem Cell Biol. 2005 Apr;37(4):720-5</RefSource>                <PMID Version="1">15694832</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2009 Sep 24;461(7263):495-500</RefSource>                <PMID Version="1">19741607</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Jun;151(2):281-94</RefSource>                <PMID Version="1">25904215</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Med. 1996 Apr 1;183(4):1797-806</RefSource>                <PMID Version="1">8666936</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2016 Jan 12;18(1):6</RefSource>                <PMID Version="1">26757880</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 May;133(1):75-87</RefSource>                <PMID Version="1">21818590</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2005 Jan 1;113(1):109-15</RefSource>                <PMID Version="1">15386420</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2001 Nov 1;414(6859):105-11</RefSource>                <PMID Version="1">11689955</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5429-38</RefSource>                <PMID Version="1">25453096</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2011 Sep 29;11:418</RefSource>                <PMID Version="1">21957977</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 Aug;122(3):795-801</RefSource>                <PMID Version="1">20571867</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2010;12(5):R68</RefSource>                <PMID Version="1">20813035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2007 May 1;109(9):1721-8</RefSource>                <PMID Version="1">17387718</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2011 Jul 1;71(13):4640-52</RefSource>                <PMID Version="1">21712410</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Carcinog. 2015 Nov;54(11):1480-93</RefSource>                <PMID Version="1">25263583</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8</RefSource>                <PMID Version="1">12629218</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2008;10(2):R25</RefSource>                <PMID Version="1">18366788</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2015 Apr 15;75(8):1691-702</RefSource>                <PMID Version="1">25660951</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Organogenesis. 2008 Apr;4(2):68-75</RefSource>                <PMID Version="1">19279717</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Biophys Res Commun. 2010 Feb 12;392(3):373-9</RefSource>                <PMID Version="1">20074550</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2006 May 15;66(10):5322-9</RefSource>                <PMID Version="1">16707458</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Biotechnol. 2009 Jan;27(1):44-6</RefSource>                <PMID Version="1">19131997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Stem Cell. 2011 Sep 2;9(3):262-71</RefSource>                <PMID Version="1">21885021</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2018 Aug;37(33):4489-4504</RefSource>                <PMID Version="1">29743588</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2009 Feb 15;69(4):1302-13</RefSource>                <PMID Version="1">19190339</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2008 Oct;111(3):419-27</RefSource>                <PMID Version="1">17965935</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74</RefSource>                <PMID Version="1">11553815</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2011 Mar 8;19(3):387-400</RefSource>                <PMID Version="1">21397861</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11298-303</RefSource>                <PMID Version="1">17581871</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Cycle. 2016 May 2;15(9):1276-87</RefSource>                <PMID Version="1">26985855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Metab. 2018 Jan 9;27(1):136-150.e5</RefSource>                <PMID Version="1">29249690</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Med. 2007;58:267-84</RefSource>                <PMID Version="1">17002552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20224-9</RefSource>                <PMID Version="1">24277854</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2006 Jun 7;295(21):2492-502</RefSource>                <PMID Version="1">16757721</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):3-9</RefSource>                <PMID Version="1">19224345</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2013 Mar 18;23(3):347-61</RefSource>                <PMID Version="1">23518349</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 Aug;122(3):777-85</RefSource>                <PMID Version="1">19898931</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stem Cell Reports. 2013 Dec 27;2(1):78-91</RefSource>                <PMID Version="1">24511467</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">BCSCs</Keyword>            <Keyword MajorTopicYN="N">BCSCs markers</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">resistance</Keyword>            <Keyword MajorTopicYN="N">targeted therapy</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>08</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>08</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30200262</ArticleId>            <ArticleId IdType="pii">molecules23092193</ArticleId>            <ArticleId IdType="doi">10.3390/molecules23092193</ArticleId>            <ArticleId IdType="pmc">PMC6225226</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>